Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing

Published:2014-07-10 Issue:8 Volume:9 Page:1848-1859
ISSN:1754-2189
Container-title:Nature Protocols
language:en
Short-container-title:Nat Protoc

Author:

Pavía-Jiménez Andrea,Tcheuyap Vanina Toffessi,Brugarolas James

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology

Link

http://www.nature.com/articles/nprot.2014.108.pdf

Reference27 articles.

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).

2. Janowitz, T., Welsh, S.J., Zaki, K., Mulders, P. & Eisen, T. Adjuvant therapy in renal cell carcinoma-past, present, and future. Semin. Oncol. 40, 482–491 (2013).

3. Ocana, A., Pandiella, A., Siu, L.L. & Tannock, I.F. Preclinical development of molecular-targeted agents for cancer. Nat. Rev. Clin. Oncol. 8, 200–209 (2011).

4. Nogawa, M. et al. Monitoring luciferase-labeled cancer cell growth and metastasis in different in vivo models. Cancer Lett. 217, 243–253 (2005).

5. Liu, J. et al. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft. Urol. Oncol. 31, 264–270 (2013).

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Curcumin Inhibits Vasculogenic Mimicry via Regulating ETS-1 in Renal Cell Carcinoma;Current Cancer Drug Targets;2024-10

2. Unconventional mechanism of action and resistance to rapalogs in renal cancer;Proceedings of the National Academy of Sciences;2024-06-11

3. Glycosaminoglycan-mediated lipoprotein uptake protects cancer cells from ferroptosis;2024-05-13

4. CLCluster: a redundancy-reduction contrastive learning-based clustering method of cancer subtype based on multi-omics data;2024-03-12

5. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis;Journal of Clinical Investigation;2024-02-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3